These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 28529067)

  • 1. Immunoproapoptotic molecule scFv-Fdt-tBid modified mesenchymal stem cells for prostate cancer dual-targeted therapy.
    Yan F; Li X; Li N; Zhang R; Wang Q; Ru Y; Hao X; Ni J; Wang H; Wu G
    Cancer Lett; 2017 Aug; 402():32-42. PubMed ID: 28529067
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potent killing of HBV-related hepatocellular carcinoma by a chimeric protein of anti-HBsAg single-chain antibody and truncated Bid.
    Yan B; Ouyang Q; Zhao Z; Cao F; Wang T; Jia X; Meng Y; Jiang S; Liu J; Chen R; Jia L; Zhang R; Wen W; Jin B; Chen S; Zhao J; Yang A
    Biomaterials; 2013 Jul; 34(20):4880-9. PubMed ID: 23562050
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dual targeting and enhanced cytotoxicity to HER2-overexpressing tumors by immunoapoptotin-armored mesenchymal stem cells.
    Cai Y; Xi Y; Cao Z; Xiang G; Ni Q; Zhang R; Chang J; Du X; Yang A; Yan B; Zhao J
    Cancer Lett; 2016 Oct; 381(1):104-12. PubMed ID: 27473824
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mesenchymal stem cells modified to express lentivirus TNF-α Tumstatin(45-132) inhibit the growth of prostate cancer.
    Zhang X; Xu W; Qian H; Zhu W; Zhang R
    J Cell Mol Med; 2011 Feb; 15(2):433-44. PubMed ID: 19799647
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective cytotoxicity to HER2-positive tumor cells by a recombinant e23sFv-TD-tBID protein containing a furin cleavage sequence.
    Wang F; Ren J; Qiu XC; Wang LF; Zhu Q; Zhang YQ; Huan Y; Meng YL; Yao LB; Chen SY; Xu YM; Yang AG
    Clin Cancer Res; 2010 Apr; 16(8):2284-94. PubMed ID: 20371697
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PSMA specific single chain antibody-mediated targeted knockdown of Notch1 inhibits human prostate cancer cell proliferation and tumor growth.
    Su Y; Yu L; Liu N; Guo Z; Wang G; Zheng J; Wei M; Wang H; Yang AG; Qin W; Wen W
    Cancer Lett; 2013 Sep; 338(2):282-91. PubMed ID: 23752065
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Construction of humanized anti-HER2 single-chain variable fragments (husFvs) and achievement of potent tumor suppression with the reconstituted husFv-Fdt-tBid immunoapoptotin.
    Ou-Yang Q; Yan B; Li A; Hu ZS; Feng JN; Lun XX; Zhang MM; Zhang MD; Wu KC; Xue FF; Yang AG; Zhao J
    Biomaterials; 2018 Sep; 178():170-182. PubMed ID: 29935385
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IFN-γ-secreting-mesenchymal stem cells exert an antitumor effect in vivo via the TRAIL pathway.
    Yang X; Du J; Xu X; Xu C; Song W
    J Immunol Res; 2014; 2014():318098. PubMed ID: 24971369
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adenovirus-mediated truncated Bid overexpression induced by the Cre/LoxP system promotes the cell apoptosis of CD133+ ovarian cancer stem cells.
    Long Q; Yang R; Lu W; Zhu W; Zhou J; Zheng C; Zhou D; Yu L; Wu J
    Oncol Rep; 2017 Jan; 37(1):155-162. PubMed ID: 27878291
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loss of let-7 microRNA upregulates IL-6 in bone marrow-derived mesenchymal stem cells triggering a reactive stromal response to prostate cancer.
    Sung SY; Liao CH; Wu HP; Hsiao WC; Wu IH; Jinpu ; Yu ; Lin SH; Hsieh CL
    PLoS One; 2013; 8(8):e71637. PubMed ID: 23977098
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prostate-specific expression of the diphtheria toxin A chain (DT-A): studies of inducibility and specificity of expression of prostate-specific antigen promoter-driven DT-A adenoviral-mediated gene transfer.
    Li Y; McCadden J; Ferrer F; Kruszewski M; Carducci M; Simons J; Rodriguez R
    Cancer Res; 2002 May; 62(9):2576-82. PubMed ID: 11980652
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dual-targeted antitumor effects against brainstem glioma by intravenous delivery of tumor necrosis factor-related, apoptosis-inducing, ligand-engineered human mesenchymal stem cells.
    Yang B; Wu X; Mao Y; Bao W; Gao L; Zhou P; Xie R; Zhou L; Zhu J
    Neurosurgery; 2009 Sep; 65(3):610-24; discussion 624. PubMed ID: 19687708
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ultrasound-Mediated Mesenchymal Stem Cells Transfection as a Targeted Cancer Therapy Platform.
    Haber T; Baruch L; Machluf M
    Sci Rep; 2017 Feb; 7():42046. PubMed ID: 28169315
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Granzyme B-based cytolytic fusion protein targeting EpCAM specifically kills triple negative breast cancer cells in vitro and inhibits tumor growth in a subcutaneous mouse tumor model.
    Amoury M; Kolberg K; Pham AT; Hristodorov D; Mladenov R; Di Fiore S; Helfrich W; Kiessling F; Fischer R; Pardo A; Thepen T; Hussain AF; Nachreiner T; Barth S
    Cancer Lett; 2016 Mar; 372(2):201-9. PubMed ID: 26806809
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mesenchymal stem cells expressing therapeutic genes induce autochthonous prostate tumour regression.
    Abrate A; Buono R; Canu T; Esposito A; Del Maschio A; Lucianò R; Bettiga A; Colciago G; Guazzoni G; Benigni F; Hedlund P; Altaner C; Montorsi F; Cavarretta IT
    Eur J Cancer; 2014 Sep; 50(14):2478-88. PubMed ID: 25060826
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cancer gene therapy using mesenchymal stem cells expressing interferon-beta in a mouse prostate cancer lung metastasis model.
    Ren C; Kumar S; Chanda D; Kallman L; Chen J; Mountz JD; Ponnazhagan S
    Gene Ther; 2008 Nov; 15(21):1446-53. PubMed ID: 18596829
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro and in vivo prodrug therapy of prostate cancer using anti-gamma-Sm-scFv/hCPA fusion protein.
    Hao XK; Liu JY; Yue QH; Wu GJ; Bai YJ; Yin Y
    Prostate; 2006 Jun; 66(8):858-66. PubMed ID: 16491483
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of different interchain linkers on biological activity of an anti-prostate cancer single-chain bispecific antibody.
    Hao CH; Han QH; Shan ZJ; Hu JT; Zhang N; Zhang XP
    Theor Biol Med Model; 2015 Aug; 12():14. PubMed ID: 26246000
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Close interactions between mesenchymal stem cells and neuroblastoma cell lines lead to tumor growth inhibition.
    Bianchi G; Morandi F; Cilli M; Daga A; Bocelli-Tyndall C; Gambini C; Pistoia V; Raffaghello L
    PLoS One; 2012; 7(10):e48654. PubMed ID: 23119082
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor immunotherapy using gene-modified human mesenchymal stem cells loaded into synthetic extracellular matrix scaffolds.
    Compte M; Cuesta AM; Sánchez-Martín D; Alonso-Camino V; Vicario JL; Sanz L; Alvarez-Vallina L
    Stem Cells; 2009 Mar; 27(3):753-60. PubMed ID: 19096041
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.